nodes	percent_of_prediction	percent_of_DWPC	metapath
Reboxetine—CYP3A4—Chenodeoxycholic acid—primary biliary cirrhosis	0.21	0.426	CbGbCtD
Reboxetine—ABCB1—Colchicine—primary biliary cirrhosis	0.177	0.359	CbGbCtD
Reboxetine—CYP3A4—Colchicine—primary biliary cirrhosis	0.106	0.215	CbGbCtD
Reboxetine—Retrosternal pain—Ursodeoxycholic acid—primary biliary cirrhosis	0.0109	0.0246	CcSEcCtD
Reboxetine—Retrosternal pain—Chenodeoxycholic acid—primary biliary cirrhosis	0.0109	0.0246	CcSEcCtD
Reboxetine—Laboratory test abnormal—Ursodeoxycholic acid—primary biliary cirrhosis	0.0105	0.0238	CcSEcCtD
Reboxetine—Laboratory test abnormal—Chenodeoxycholic acid—primary biliary cirrhosis	0.0105	0.0238	CcSEcCtD
Reboxetine—Duodenal ulcer—Ursodeoxycholic acid—primary biliary cirrhosis	0.00905	0.0205	CcSEcCtD
Reboxetine—Duodenal ulcer—Chenodeoxycholic acid—primary biliary cirrhosis	0.00905	0.0205	CcSEcCtD
Reboxetine—ABCB1—Drug Induction of Bile Acid Pathway—SLC51B—primary biliary cirrhosis	0.00654	0.0984	CbGpPWpGaD
Reboxetine—Gamma-glutamyltransferase increased—Chenodeoxycholic acid—primary biliary cirrhosis	0.00532	0.0121	CcSEcCtD
Reboxetine—Gamma-glutamyltransferase increased—Ursodeoxycholic acid—primary biliary cirrhosis	0.00532	0.0121	CcSEcCtD
Reboxetine—ABCB1—Drug Induction of Bile Acid Pathway—SLC51A—primary biliary cirrhosis	0.00495	0.0746	CbGpPWpGaD
Reboxetine—Viral infection—Ursodeoxycholic acid—primary biliary cirrhosis	0.00484	0.011	CcSEcCtD
Reboxetine—Viral infection—Chenodeoxycholic acid—primary biliary cirrhosis	0.00484	0.011	CcSEcCtD
Reboxetine—Neck pain—Ursodeoxycholic acid—primary biliary cirrhosis	0.00443	0.01	CcSEcCtD
Reboxetine—Neck pain—Chenodeoxycholic acid—primary biliary cirrhosis	0.00443	0.01	CcSEcCtD
Reboxetine—Urinary incontinence—Ursodeoxycholic acid—primary biliary cirrhosis	0.00422	0.00958	CcSEcCtD
Reboxetine—Urinary incontinence—Chenodeoxycholic acid—primary biliary cirrhosis	0.00422	0.00958	CcSEcCtD
Reboxetine—CYP3A4—Drug Induction of Bile Acid Pathway—SLC51B—primary biliary cirrhosis	0.00403	0.0606	CbGpPWpGaD
Reboxetine—ABCB1—Abacavir transmembrane transport—ABCG2—primary biliary cirrhosis	0.00338	0.0509	CbGpPWpGaD
Reboxetine—Blood creatinine increased—Colchicine—primary biliary cirrhosis	0.00331	0.00751	CcSEcCtD
Reboxetine—Dehydration—Colchicine—primary biliary cirrhosis	0.00329	0.00746	CcSEcCtD
Reboxetine—Diplopia—Ursodeoxycholic acid—primary biliary cirrhosis	0.00317	0.0072	CcSEcCtD
Reboxetine—Diplopia—Chenodeoxycholic acid—primary biliary cirrhosis	0.00317	0.0072	CcSEcCtD
Reboxetine—Alanine aminotransferase increased—Colchicine—primary biliary cirrhosis	0.00312	0.00707	CcSEcCtD
Reboxetine—Muscular weakness—Colchicine—primary biliary cirrhosis	0.00312	0.00707	CcSEcCtD
Reboxetine—Face oedema—Ursodeoxycholic acid—primary biliary cirrhosis	0.00307	0.00695	CcSEcCtD
Reboxetine—Face oedema—Chenodeoxycholic acid—primary biliary cirrhosis	0.00307	0.00695	CcSEcCtD
Reboxetine—CYP3A4—Drug Induction of Bile Acid Pathway—SLC51A—primary biliary cirrhosis	0.00305	0.0459	CbGpPWpGaD
Reboxetine—Blood creatinine increased—Ursodeoxycholic acid—primary biliary cirrhosis	0.00297	0.00675	CcSEcCtD
Reboxetine—Blood creatinine increased—Chenodeoxycholic acid—primary biliary cirrhosis	0.00297	0.00675	CcSEcCtD
Reboxetine—Dehydration—Ursodeoxycholic acid—primary biliary cirrhosis	0.00295	0.0067	CcSEcCtD
Reboxetine—Dehydration—Chenodeoxycholic acid—primary biliary cirrhosis	0.00295	0.0067	CcSEcCtD
Reboxetine—Liver function test abnormal—Chenodeoxycholic acid—primary biliary cirrhosis	0.00293	0.00665	CcSEcCtD
Reboxetine—Liver function test abnormal—Ursodeoxycholic acid—primary biliary cirrhosis	0.00293	0.00665	CcSEcCtD
Reboxetine—Orthostatic hypotension—Chenodeoxycholic acid—primary biliary cirrhosis	0.0029	0.00658	CcSEcCtD
Reboxetine—Orthostatic hypotension—Ursodeoxycholic acid—primary biliary cirrhosis	0.0029	0.00658	CcSEcCtD
Reboxetine—Breast disorder—Chenodeoxycholic acid—primary biliary cirrhosis	0.00287	0.00651	CcSEcCtD
Reboxetine—Breast disorder—Ursodeoxycholic acid—primary biliary cirrhosis	0.00287	0.00651	CcSEcCtD
Reboxetine—Alanine aminotransferase increased—Ursodeoxycholic acid—primary biliary cirrhosis	0.0028	0.00635	CcSEcCtD
Reboxetine—Alanine aminotransferase increased—Chenodeoxycholic acid—primary biliary cirrhosis	0.0028	0.00635	CcSEcCtD
Reboxetine—Influenza—Ursodeoxycholic acid—primary biliary cirrhosis	0.00274	0.00623	CcSEcCtD
Reboxetine—Influenza—Chenodeoxycholic acid—primary biliary cirrhosis	0.00274	0.00623	CcSEcCtD
Reboxetine—ABCB1—Codeine and Morphine Metabolism—ABCC2—primary biliary cirrhosis	0.00273	0.0411	CbGpPWpGaD
Reboxetine—Bronchitis—Ursodeoxycholic acid—primary biliary cirrhosis	0.00264	0.00599	CcSEcCtD
Reboxetine—Bronchitis—Chenodeoxycholic acid—primary biliary cirrhosis	0.00264	0.00599	CcSEcCtD
Reboxetine—CYP2D6—Codeine and Morphine Metabolism—ABCC2—primary biliary cirrhosis	0.00257	0.0387	CbGpPWpGaD
Reboxetine—Dysuria—Ursodeoxycholic acid—primary biliary cirrhosis	0.00257	0.00582	CcSEcCtD
Reboxetine—Dysuria—Chenodeoxycholic acid—primary biliary cirrhosis	0.00257	0.00582	CcSEcCtD
Reboxetine—Pollakiuria—Chenodeoxycholic acid—primary biliary cirrhosis	0.00253	0.00575	CcSEcCtD
Reboxetine—Pollakiuria—Ursodeoxycholic acid—primary biliary cirrhosis	0.00253	0.00575	CcSEcCtD
Reboxetine—Weight decreased—Ursodeoxycholic acid—primary biliary cirrhosis	0.00248	0.00563	CcSEcCtD
Reboxetine—Weight decreased—Chenodeoxycholic acid—primary biliary cirrhosis	0.00248	0.00563	CcSEcCtD
Reboxetine—Infestation NOS—Ursodeoxycholic acid—primary biliary cirrhosis	0.00245	0.00555	CcSEcCtD
Reboxetine—Infestation—Ursodeoxycholic acid—primary biliary cirrhosis	0.00245	0.00555	CcSEcCtD
Reboxetine—Infestation—Chenodeoxycholic acid—primary biliary cirrhosis	0.00245	0.00555	CcSEcCtD
Reboxetine—Infestation NOS—Chenodeoxycholic acid—primary biliary cirrhosis	0.00245	0.00555	CcSEcCtD
Reboxetine—Conjunctivitis—Ursodeoxycholic acid—primary biliary cirrhosis	0.00238	0.0054	CcSEcCtD
Reboxetine—Conjunctivitis—Chenodeoxycholic acid—primary biliary cirrhosis	0.00238	0.0054	CcSEcCtD
Reboxetine—Urinary tract infection—Chenodeoxycholic acid—primary biliary cirrhosis	0.00238	0.0054	CcSEcCtD
Reboxetine—Urinary tract infection—Ursodeoxycholic acid—primary biliary cirrhosis	0.00238	0.0054	CcSEcCtD
Reboxetine—Sweating—Ursodeoxycholic acid—primary biliary cirrhosis	0.00235	0.00532	CcSEcCtD
Reboxetine—Sweating—Chenodeoxycholic acid—primary biliary cirrhosis	0.00235	0.00532	CcSEcCtD
Reboxetine—Epistaxis—Ursodeoxycholic acid—primary biliary cirrhosis	0.00231	0.00524	CcSEcCtD
Reboxetine—Epistaxis—Chenodeoxycholic acid—primary biliary cirrhosis	0.00231	0.00524	CcSEcCtD
Reboxetine—Sinusitis—Ursodeoxycholic acid—primary biliary cirrhosis	0.0023	0.00521	CcSEcCtD
Reboxetine—Sinusitis—Chenodeoxycholic acid—primary biliary cirrhosis	0.0023	0.00521	CcSEcCtD
Reboxetine—Eye disorder—Colchicine—primary biliary cirrhosis	0.00228	0.00518	CcSEcCtD
Reboxetine—Mediastinal disorder—Colchicine—primary biliary cirrhosis	0.0022	0.005	CcSEcCtD
Reboxetine—Rhinitis—Chenodeoxycholic acid—primary biliary cirrhosis	0.0022	0.005	CcSEcCtD
Reboxetine—Rhinitis—Ursodeoxycholic acid—primary biliary cirrhosis	0.0022	0.005	CcSEcCtD
Reboxetine—Pharyngitis—Ursodeoxycholic acid—primary biliary cirrhosis	0.00218	0.00495	CcSEcCtD
Reboxetine—Pharyngitis—Chenodeoxycholic acid—primary biliary cirrhosis	0.00218	0.00495	CcSEcCtD
Reboxetine—Urinary tract disorder—Chenodeoxycholic acid—primary biliary cirrhosis	0.00217	0.00492	CcSEcCtD
Reboxetine—Urinary tract disorder—Ursodeoxycholic acid—primary biliary cirrhosis	0.00217	0.00492	CcSEcCtD
Reboxetine—Connective tissue disorder—Chenodeoxycholic acid—primary biliary cirrhosis	0.00216	0.0049	CcSEcCtD
Reboxetine—Connective tissue disorder—Ursodeoxycholic acid—primary biliary cirrhosis	0.00216	0.0049	CcSEcCtD
Reboxetine—Urethral disorder—Chenodeoxycholic acid—primary biliary cirrhosis	0.00215	0.00488	CcSEcCtD
Reboxetine—Urethral disorder—Ursodeoxycholic acid—primary biliary cirrhosis	0.00215	0.00488	CcSEcCtD
Reboxetine—Malnutrition—Colchicine—primary biliary cirrhosis	0.00213	0.00483	CcSEcCtD
Reboxetine—Visual impairment—Ursodeoxycholic acid—primary biliary cirrhosis	0.00212	0.0048	CcSEcCtD
Reboxetine—Visual impairment—Chenodeoxycholic acid—primary biliary cirrhosis	0.00212	0.0048	CcSEcCtD
Reboxetine—Eye disorder—Chenodeoxycholic acid—primary biliary cirrhosis	0.00205	0.00466	CcSEcCtD
Reboxetine—Eye disorder—Ursodeoxycholic acid—primary biliary cirrhosis	0.00205	0.00466	CcSEcCtD
Reboxetine—Tinnitus—Ursodeoxycholic acid—primary biliary cirrhosis	0.00205	0.00465	CcSEcCtD
Reboxetine—Tinnitus—Chenodeoxycholic acid—primary biliary cirrhosis	0.00205	0.00465	CcSEcCtD
Reboxetine—Cardiac disorder—Ursodeoxycholic acid—primary biliary cirrhosis	0.00204	0.00462	CcSEcCtD
Reboxetine—Cardiac disorder—Chenodeoxycholic acid—primary biliary cirrhosis	0.00204	0.00462	CcSEcCtD
Reboxetine—Angiopathy—Ursodeoxycholic acid—primary biliary cirrhosis	0.00199	0.00452	CcSEcCtD
Reboxetine—Angiopathy—Chenodeoxycholic acid—primary biliary cirrhosis	0.00199	0.00452	CcSEcCtD
Reboxetine—Immune system disorder—Ursodeoxycholic acid—primary biliary cirrhosis	0.00198	0.0045	CcSEcCtD
Reboxetine—Immune system disorder—Chenodeoxycholic acid—primary biliary cirrhosis	0.00198	0.0045	CcSEcCtD
Reboxetine—Mediastinal disorder—Chenodeoxycholic acid—primary biliary cirrhosis	0.00198	0.00449	CcSEcCtD
Reboxetine—Mediastinal disorder—Ursodeoxycholic acid—primary biliary cirrhosis	0.00198	0.00449	CcSEcCtD
Reboxetine—Chills—Ursodeoxycholic acid—primary biliary cirrhosis	0.00197	0.00447	CcSEcCtD
Reboxetine—Chills—Chenodeoxycholic acid—primary biliary cirrhosis	0.00197	0.00447	CcSEcCtD
Reboxetine—Anaemia—Colchicine—primary biliary cirrhosis	0.00197	0.00446	CcSEcCtD
Reboxetine—ABCB1—Abacavir transport and metabolism—ABCG2—primary biliary cirrhosis	0.00194	0.0292	CbGpPWpGaD
Reboxetine—Malnutrition—Chenodeoxycholic acid—primary biliary cirrhosis	0.00191	0.00434	CcSEcCtD
Reboxetine—Malnutrition—Ursodeoxycholic acid—primary biliary cirrhosis	0.00191	0.00434	CcSEcCtD
Reboxetine—Leukopenia—Colchicine—primary biliary cirrhosis	0.0019	0.00432	CcSEcCtD
Reboxetine—Tension—Ursodeoxycholic acid—primary biliary cirrhosis	0.00188	0.00426	CcSEcCtD
Reboxetine—Tension—Chenodeoxycholic acid—primary biliary cirrhosis	0.00188	0.00426	CcSEcCtD
Reboxetine—Nervousness—Chenodeoxycholic acid—primary biliary cirrhosis	0.00186	0.00421	CcSEcCtD
Reboxetine—Nervousness—Ursodeoxycholic acid—primary biliary cirrhosis	0.00186	0.00421	CcSEcCtD
Reboxetine—Ill-defined disorder—Chenodeoxycholic acid—primary biliary cirrhosis	0.00177	0.00402	CcSEcCtD
Reboxetine—Ill-defined disorder—Ursodeoxycholic acid—primary biliary cirrhosis	0.00177	0.00402	CcSEcCtD
Reboxetine—Anaemia—Chenodeoxycholic acid—primary biliary cirrhosis	0.00177	0.00401	CcSEcCtD
Reboxetine—Anaemia—Ursodeoxycholic acid—primary biliary cirrhosis	0.00177	0.00401	CcSEcCtD
Reboxetine—Malaise—Chenodeoxycholic acid—primary biliary cirrhosis	0.00172	0.00391	CcSEcCtD
Reboxetine—Malaise—Ursodeoxycholic acid—primary biliary cirrhosis	0.00172	0.00391	CcSEcCtD
Reboxetine—Vertigo—Chenodeoxycholic acid—primary biliary cirrhosis	0.00172	0.0039	CcSEcCtD
Reboxetine—Vertigo—Ursodeoxycholic acid—primary biliary cirrhosis	0.00172	0.0039	CcSEcCtD
Reboxetine—Syncope—Ursodeoxycholic acid—primary biliary cirrhosis	0.00171	0.00389	CcSEcCtD
Reboxetine—Syncope—Chenodeoxycholic acid—primary biliary cirrhosis	0.00171	0.00389	CcSEcCtD
Reboxetine—Leukopenia—Chenodeoxycholic acid—primary biliary cirrhosis	0.00171	0.00388	CcSEcCtD
Reboxetine—Leukopenia—Ursodeoxycholic acid—primary biliary cirrhosis	0.00171	0.00388	CcSEcCtD
Reboxetine—Shock—Colchicine—primary biliary cirrhosis	0.00171	0.00388	CcSEcCtD
Reboxetine—Nervous system disorder—Colchicine—primary biliary cirrhosis	0.0017	0.00386	CcSEcCtD
Reboxetine—Palpitations—Ursodeoxycholic acid—primary biliary cirrhosis	0.00169	0.00383	CcSEcCtD
Reboxetine—Palpitations—Chenodeoxycholic acid—primary biliary cirrhosis	0.00169	0.00383	CcSEcCtD
Reboxetine—Skin disorder—Colchicine—primary biliary cirrhosis	0.00169	0.00383	CcSEcCtD
Reboxetine—CYP3A4—Codeine and Morphine Metabolism—ABCC2—primary biliary cirrhosis	0.00168	0.0253	CbGpPWpGaD
Reboxetine—Loss of consciousness—Ursodeoxycholic acid—primary biliary cirrhosis	0.00168	0.00381	CcSEcCtD
Reboxetine—Loss of consciousness—Chenodeoxycholic acid—primary biliary cirrhosis	0.00168	0.00381	CcSEcCtD
Reboxetine—Hypertension—Chenodeoxycholic acid—primary biliary cirrhosis	0.00165	0.00375	CcSEcCtD
Reboxetine—Hypertension—Ursodeoxycholic acid—primary biliary cirrhosis	0.00165	0.00375	CcSEcCtD
Reboxetine—Chest pain—Ursodeoxycholic acid—primary biliary cirrhosis	0.00163	0.00369	CcSEcCtD
Reboxetine—Chest pain—Chenodeoxycholic acid—primary biliary cirrhosis	0.00163	0.00369	CcSEcCtD
Reboxetine—Hypotension—Colchicine—primary biliary cirrhosis	0.00162	0.00368	CcSEcCtD
Reboxetine—Unspecified disorder of skin and subcutaneous tissue—Ursodeoxycholic acid—primary biliary cirrhosis	0.00162	0.00367	CcSEcCtD
Reboxetine—Unspecified disorder of skin and subcutaneous tissue—Chenodeoxycholic acid—primary biliary cirrhosis	0.00162	0.00367	CcSEcCtD
Reboxetine—Discomfort—Chenodeoxycholic acid—primary biliary cirrhosis	0.00161	0.00365	CcSEcCtD
Reboxetine—Discomfort—Ursodeoxycholic acid—primary biliary cirrhosis	0.00161	0.00365	CcSEcCtD
Reboxetine—Dry mouth—Chenodeoxycholic acid—primary biliary cirrhosis	0.00159	0.00361	CcSEcCtD
Reboxetine—Dry mouth—Ursodeoxycholic acid—primary biliary cirrhosis	0.00159	0.00361	CcSEcCtD
Reboxetine—Confusional state—Ursodeoxycholic acid—primary biliary cirrhosis	0.00157	0.00357	CcSEcCtD
Reboxetine—Confusional state—Chenodeoxycholic acid—primary biliary cirrhosis	0.00157	0.00357	CcSEcCtD
Reboxetine—Infection—Ursodeoxycholic acid—primary biliary cirrhosis	0.00155	0.00352	CcSEcCtD
Reboxetine—Infection—Chenodeoxycholic acid—primary biliary cirrhosis	0.00155	0.00352	CcSEcCtD
Reboxetine—Shock—Ursodeoxycholic acid—primary biliary cirrhosis	0.00154	0.00348	CcSEcCtD
Reboxetine—Shock—Chenodeoxycholic acid—primary biliary cirrhosis	0.00154	0.00348	CcSEcCtD
Reboxetine—Nervous system disorder—Chenodeoxycholic acid—primary biliary cirrhosis	0.00153	0.00347	CcSEcCtD
Reboxetine—Nervous system disorder—Ursodeoxycholic acid—primary biliary cirrhosis	0.00153	0.00347	CcSEcCtD
Reboxetine—Tachycardia—Ursodeoxycholic acid—primary biliary cirrhosis	0.00152	0.00346	CcSEcCtD
Reboxetine—Tachycardia—Chenodeoxycholic acid—primary biliary cirrhosis	0.00152	0.00346	CcSEcCtD
Reboxetine—Skin disorder—Ursodeoxycholic acid—primary biliary cirrhosis	0.00152	0.00344	CcSEcCtD
Reboxetine—Skin disorder—Chenodeoxycholic acid—primary biliary cirrhosis	0.00152	0.00344	CcSEcCtD
Reboxetine—Decreased appetite—Colchicine—primary biliary cirrhosis	0.00151	0.00343	CcSEcCtD
Reboxetine—Hyperhidrosis—Ursodeoxycholic acid—primary biliary cirrhosis	0.00151	0.00342	CcSEcCtD
Reboxetine—Hyperhidrosis—Chenodeoxycholic acid—primary biliary cirrhosis	0.00151	0.00342	CcSEcCtD
Reboxetine—Gastrointestinal disorder—Colchicine—primary biliary cirrhosis	0.0015	0.0034	CcSEcCtD
Reboxetine—ABCB1—Drug Induction of Bile Acid Pathway—ABCC2—primary biliary cirrhosis	0.00149	0.0225	CbGpPWpGaD
Reboxetine—Anorexia—Ursodeoxycholic acid—primary biliary cirrhosis	0.00149	0.00337	CcSEcCtD
Reboxetine—Anorexia—Chenodeoxycholic acid—primary biliary cirrhosis	0.00149	0.00337	CcSEcCtD
Reboxetine—Hypotension—Ursodeoxycholic acid—primary biliary cirrhosis	0.00146	0.00331	CcSEcCtD
Reboxetine—Hypotension—Chenodeoxycholic acid—primary biliary cirrhosis	0.00146	0.00331	CcSEcCtD
Reboxetine—Gastrointestinal pain—Colchicine—primary biliary cirrhosis	0.00142	0.00322	CcSEcCtD
Reboxetine—Insomnia—Ursodeoxycholic acid—primary biliary cirrhosis	0.00141	0.0032	CcSEcCtD
Reboxetine—Insomnia—Chenodeoxycholic acid—primary biliary cirrhosis	0.00141	0.0032	CcSEcCtD
Reboxetine—Paraesthesia—Ursodeoxycholic acid—primary biliary cirrhosis	0.0014	0.00318	CcSEcCtD
Reboxetine—Paraesthesia—Chenodeoxycholic acid—primary biliary cirrhosis	0.0014	0.00318	CcSEcCtD
Reboxetine—Dyspnoea—Chenodeoxycholic acid—primary biliary cirrhosis	0.00139	0.00316	CcSEcCtD
Reboxetine—Dyspnoea—Ursodeoxycholic acid—primary biliary cirrhosis	0.00139	0.00316	CcSEcCtD
Reboxetine—Somnolence—Ursodeoxycholic acid—primary biliary cirrhosis	0.00139	0.00315	CcSEcCtD
Reboxetine—Somnolence—Chenodeoxycholic acid—primary biliary cirrhosis	0.00139	0.00315	CcSEcCtD
Reboxetine—Urticaria—Colchicine—primary biliary cirrhosis	0.00138	0.00313	CcSEcCtD
Reboxetine—Dyspepsia—Chenodeoxycholic acid—primary biliary cirrhosis	0.00137	0.00312	CcSEcCtD
Reboxetine—Dyspepsia—Ursodeoxycholic acid—primary biliary cirrhosis	0.00137	0.00312	CcSEcCtD
Reboxetine—Abdominal pain—Colchicine—primary biliary cirrhosis	0.00137	0.00311	CcSEcCtD
Reboxetine—Decreased appetite—Ursodeoxycholic acid—primary biliary cirrhosis	0.00136	0.00308	CcSEcCtD
Reboxetine—Decreased appetite—Chenodeoxycholic acid—primary biliary cirrhosis	0.00136	0.00308	CcSEcCtD
Reboxetine—Gastrointestinal disorder—Ursodeoxycholic acid—primary biliary cirrhosis	0.00135	0.00306	CcSEcCtD
Reboxetine—Gastrointestinal disorder—Chenodeoxycholic acid—primary biliary cirrhosis	0.00135	0.00306	CcSEcCtD
Reboxetine—Constipation—Ursodeoxycholic acid—primary biliary cirrhosis	0.00133	0.00303	CcSEcCtD
Reboxetine—Constipation—Chenodeoxycholic acid—primary biliary cirrhosis	0.00133	0.00303	CcSEcCtD
Reboxetine—ABCB1—Nuclear Receptors in Lipid Metabolism and Toxicity—ABCB4—primary biliary cirrhosis	0.00131	0.0197	CbGpPWpGaD
Reboxetine—Feeling abnormal—Ursodeoxycholic acid—primary biliary cirrhosis	0.00129	0.00292	CcSEcCtD
Reboxetine—Feeling abnormal—Chenodeoxycholic acid—primary biliary cirrhosis	0.00129	0.00292	CcSEcCtD
Reboxetine—CYP3A4—Farnesoid X Receptor  Pathway—ABCB4—primary biliary cirrhosis	0.00128	0.0193	CbGpPWpGaD
Reboxetine—Hypersensitivity—Colchicine—primary biliary cirrhosis	0.00128	0.0029	CcSEcCtD
Reboxetine—Gastrointestinal pain—Chenodeoxycholic acid—primary biliary cirrhosis	0.00128	0.00289	CcSEcCtD
Reboxetine—Gastrointestinal pain—Ursodeoxycholic acid—primary biliary cirrhosis	0.00128	0.00289	CcSEcCtD
Reboxetine—Asthenia—Colchicine—primary biliary cirrhosis	0.00125	0.00283	CcSEcCtD
Reboxetine—Urticaria—Ursodeoxycholic acid—primary biliary cirrhosis	0.00124	0.00281	CcSEcCtD
Reboxetine—Urticaria—Chenodeoxycholic acid—primary biliary cirrhosis	0.00124	0.00281	CcSEcCtD
Reboxetine—Abdominal pain—Ursodeoxycholic acid—primary biliary cirrhosis	0.00123	0.0028	CcSEcCtD
Reboxetine—Body temperature increased—Chenodeoxycholic acid—primary biliary cirrhosis	0.00123	0.0028	CcSEcCtD
Reboxetine—Abdominal pain—Chenodeoxycholic acid—primary biliary cirrhosis	0.00123	0.0028	CcSEcCtD
Reboxetine—Body temperature increased—Ursodeoxycholic acid—primary biliary cirrhosis	0.00123	0.0028	CcSEcCtD
Reboxetine—Diarrhoea—Colchicine—primary biliary cirrhosis	0.00119	0.0027	CcSEcCtD
Reboxetine—Hypersensitivity—Ursodeoxycholic acid—primary biliary cirrhosis	0.00115	0.00261	CcSEcCtD
Reboxetine—Hypersensitivity—Chenodeoxycholic acid—primary biliary cirrhosis	0.00115	0.00261	CcSEcCtD
Reboxetine—Asthenia—Ursodeoxycholic acid—primary biliary cirrhosis	0.00112	0.00254	CcSEcCtD
Reboxetine—Asthenia—Chenodeoxycholic acid—primary biliary cirrhosis	0.00112	0.00254	CcSEcCtD
Reboxetine—Vomiting—Colchicine—primary biliary cirrhosis	0.0011	0.00251	CcSEcCtD
Reboxetine—Rash—Colchicine—primary biliary cirrhosis	0.0011	0.00248	CcSEcCtD
Reboxetine—Dermatitis—Colchicine—primary biliary cirrhosis	0.00109	0.00248	CcSEcCtD
Reboxetine—Headache—Colchicine—primary biliary cirrhosis	0.00109	0.00247	CcSEcCtD
Reboxetine—CYP3A4—Irinotecan Pathway—ABCC2—primary biliary cirrhosis	0.00108	0.0162	CbGpPWpGaD
Reboxetine—Diarrhoea—Chenodeoxycholic acid—primary biliary cirrhosis	0.00107	0.00242	CcSEcCtD
Reboxetine—Diarrhoea—Ursodeoxycholic acid—primary biliary cirrhosis	0.00107	0.00242	CcSEcCtD
Reboxetine—Dizziness—Chenodeoxycholic acid—primary biliary cirrhosis	0.00103	0.00234	CcSEcCtD
Reboxetine—Dizziness—Ursodeoxycholic acid—primary biliary cirrhosis	0.00103	0.00234	CcSEcCtD
Reboxetine—Nausea—Colchicine—primary biliary cirrhosis	0.00103	0.00234	CcSEcCtD
Reboxetine—SLC6A4—Monoamine Transport—AGT—primary biliary cirrhosis	0.00103	0.0155	CbGpPWpGaD
Reboxetine—Vomiting—Ursodeoxycholic acid—primary biliary cirrhosis	0.000992	0.00225	CcSEcCtD
Reboxetine—Vomiting—Chenodeoxycholic acid—primary biliary cirrhosis	0.000992	0.00225	CcSEcCtD
Reboxetine—Rash—Ursodeoxycholic acid—primary biliary cirrhosis	0.000984	0.00223	CcSEcCtD
Reboxetine—Rash—Chenodeoxycholic acid—primary biliary cirrhosis	0.000984	0.00223	CcSEcCtD
Reboxetine—Dermatitis—Ursodeoxycholic acid—primary biliary cirrhosis	0.000983	0.00223	CcSEcCtD
Reboxetine—Dermatitis—Chenodeoxycholic acid—primary biliary cirrhosis	0.000983	0.00223	CcSEcCtD
Reboxetine—Headache—Ursodeoxycholic acid—primary biliary cirrhosis	0.000978	0.00222	CcSEcCtD
Reboxetine—Headache—Chenodeoxycholic acid—primary biliary cirrhosis	0.000978	0.00222	CcSEcCtD
Reboxetine—SLC6A2—SLC-mediated transmembrane transport—SLC4A2—primary biliary cirrhosis	0.000962	0.0145	CbGpPWpGaD
Reboxetine—Nausea—Ursodeoxycholic acid—primary biliary cirrhosis	0.000927	0.0021	CcSEcCtD
Reboxetine—Nausea—Chenodeoxycholic acid—primary biliary cirrhosis	0.000927	0.0021	CcSEcCtD
Reboxetine—CYP3A4—Drug Induction of Bile Acid Pathway—ABCC2—primary biliary cirrhosis	0.000921	0.0139	CbGpPWpGaD
Reboxetine—CYP3A4—Irinotecan Pathway—ABCG2—primary biliary cirrhosis	0.000915	0.0138	CbGpPWpGaD
Reboxetine—ABCB1—Constitutive Androstane Receptor Pathway—ABCC2—primary biliary cirrhosis	0.000901	0.0136	CbGpPWpGaD
Reboxetine—SLC6A2—Monoamine Transport—AGT—primary biliary cirrhosis	0.000885	0.0133	CbGpPWpGaD
Reboxetine—ABCB1—Nuclear Receptors in Lipid Metabolism and Toxicity—ABCC2—primary biliary cirrhosis	0.000858	0.0129	CbGpPWpGaD
Reboxetine—ABCB1—ABC-family proteins mediated transport—ABCC2—primary biliary cirrhosis	0.00082	0.0123	CbGpPWpGaD
Reboxetine—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—ABCB4—primary biliary cirrhosis	0.000805	0.0121	CbGpPWpGaD
Reboxetine—CYP3A4—Tryptophan metabolism—OGDH—primary biliary cirrhosis	0.000754	0.0114	CbGpPWpGaD
Reboxetine—SLC6A4—NRF2 pathway—ABCC2—primary biliary cirrhosis	0.000707	0.0106	CbGpPWpGaD
Reboxetine—SLC6A4—SIDS Susceptibility Pathways—AQP4—primary biliary cirrhosis	0.000699	0.0105	CbGpPWpGaD
Reboxetine—SLC6A2—NRF2 pathway—ABCC2—primary biliary cirrhosis	0.000608	0.00915	CbGpPWpGaD
Reboxetine—HTR2C—GPCRs, Class A Rhodopsin-like—MAS1—primary biliary cirrhosis	0.000591	0.0089	CbGpPWpGaD
Reboxetine—ABCB1—Allograft Rejection—CXCR5—primary biliary cirrhosis	0.000555	0.00836	CbGpPWpGaD
Reboxetine—CYP3A4—Constitutive Androstane Receptor Pathway—ABCC2—primary biliary cirrhosis	0.000555	0.00836	CbGpPWpGaD
Reboxetine—ABCB1—Imatinib Resistance in Chronic Myeloid Leukemia—ABCG2—primary biliary cirrhosis	0.000545	0.0082	CbGpPWpGaD
Reboxetine—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—ABCC2—primary biliary cirrhosis	0.000529	0.00796	CbGpPWpGaD
Reboxetine—CYP3A4—Aflatoxin activation and detoxification—GGT1—primary biliary cirrhosis	0.000526	0.00791	CbGpPWpGaD
Reboxetine—ABCB1—Allograft Rejection—CXCL9—primary biliary cirrhosis	0.000504	0.00759	CbGpPWpGaD
Reboxetine—ABCB1—Constitutive Androstane Receptor Pathway—PPARGC1A—primary biliary cirrhosis	0.0005	0.00753	CbGpPWpGaD
Reboxetine—ABCB1—Allograft Rejection—IL12A—primary biliary cirrhosis	0.000491	0.00739	CbGpPWpGaD
Reboxetine—SLC6A2—Transmembrane transport of small molecules—SLC4A2—primary biliary cirrhosis	0.000489	0.00736	CbGpPWpGaD
Reboxetine—ABCB1—HIF-1-alpha transcription factor network—IGFBP1—primary biliary cirrhosis	0.000482	0.00725	CbGpPWpGaD
Reboxetine—CYP3A4—Farnesoid X Receptor  Pathway—PPARGC1A—primary biliary cirrhosis	0.000468	0.00704	CbGpPWpGaD
Reboxetine—SLC6A4—NRF2 pathway—GGT1—primary biliary cirrhosis	0.000441	0.00664	CbGpPWpGaD
Reboxetine—ABCB1—HIF-1-alpha transcription factor network—ABCG2—primary biliary cirrhosis	0.000429	0.00646	CbGpPWpGaD
Reboxetine—HTR2C—GPCRs, Class A Rhodopsin-like—CXCR5—primary biliary cirrhosis	0.000394	0.00594	CbGpPWpGaD
Reboxetine—SLC6A2—NRF2 pathway—GGT1—primary biliary cirrhosis	0.000379	0.00571	CbGpPWpGaD
Reboxetine—SLC6A4—SIDS Susceptibility Pathways—PPARGC1A—primary biliary cirrhosis	0.000372	0.0056	CbGpPWpGaD
Reboxetine—SLC6A2—SLC-mediated transmembrane transport—NUP210—primary biliary cirrhosis	0.00035	0.00527	CbGpPWpGaD
Reboxetine—HTR2C—Class A/1 (Rhodopsin-like receptors)—CXCR5—primary biliary cirrhosis	0.000338	0.00509	CbGpPWpGaD
Reboxetine—ABCB1—Integrated Pancreatic Cancer Pathway—DAG1—primary biliary cirrhosis	0.000311	0.00469	CbGpPWpGaD
Reboxetine—CYP3A4—Constitutive Androstane Receptor Pathway—PPARGC1A—primary biliary cirrhosis	0.000308	0.00464	CbGpPWpGaD
Reboxetine—ABCB1—Allograft Rejection—IL12B—primary biliary cirrhosis	0.000308	0.00464	CbGpPWpGaD
Reboxetine—HTR2C—Class A/1 (Rhodopsin-like receptors)—CXCL9—primary biliary cirrhosis	0.000307	0.00462	CbGpPWpGaD
Reboxetine—SLC6A4—Circadian rythm related genes—PPARGC1A—primary biliary cirrhosis	0.000304	0.00457	CbGpPWpGaD
Reboxetine—SLC6A4—SIDS Susceptibility Pathways—HIF1A—primary biliary cirrhosis	0.000291	0.00438	CbGpPWpGaD
Reboxetine—ABCB1—Allograft Rejection—CTLA4—primary biliary cirrhosis	0.00029	0.00436	CbGpPWpGaD
Reboxetine—HTR2C—GPCR ligand binding—CXCR5—primary biliary cirrhosis	0.000257	0.00387	CbGpPWpGaD
Reboxetine—HTR2C—GPCR ligand binding—CXCL9—primary biliary cirrhosis	0.000234	0.00352	CbGpPWpGaD
Reboxetine—CYP2D6—Melatonin metabolism and effects—NFKB1—primary biliary cirrhosis	0.000232	0.00349	CbGpPWpGaD
Reboxetine—ABCB1—Allograft Rejection—CD40LG—primary biliary cirrhosis	0.000225	0.00339	CbGpPWpGaD
Reboxetine—ABCB1—HIF-1-alpha transcription factor network—HIF1A—primary biliary cirrhosis	0.000219	0.0033	CbGpPWpGaD
Reboxetine—ABCB1—Allograft Rejection—IL4—primary biliary cirrhosis	0.000219	0.0033	CbGpPWpGaD
Reboxetine—SLC6A4—Circadian rythm related genes—NOS2—primary biliary cirrhosis	0.000216	0.00325	CbGpPWpGaD
Reboxetine—ABCB1—Transmembrane transport of small molecules—SLC4A2—primary biliary cirrhosis	0.000215	0.00324	CbGpPWpGaD
Reboxetine—SLC6A2—Transmembrane transport of small molecules—AQP4—primary biliary cirrhosis	0.000203	0.00306	CbGpPWpGaD
Reboxetine—ABCB1—HIF-1-alpha transcription factor network—NOS2—primary biliary cirrhosis	0.000199	0.003	CbGpPWpGaD
Reboxetine—HTR2C—Gastrin-CREB signalling pathway via PKC and MAPK—MMP3—primary biliary cirrhosis	0.000197	0.00296	CbGpPWpGaD
Reboxetine—SLC6A2—Transmembrane transport of small molecules—ABCC2—primary biliary cirrhosis	0.000195	0.00293	CbGpPWpGaD
Reboxetine—SLC6A2—Transmembrane transport of small molecules—NUP210—primary biliary cirrhosis	0.000178	0.00268	CbGpPWpGaD
Reboxetine—HTR2C—G alpha (q) signalling events—AGT—primary biliary cirrhosis	0.000174	0.00262	CbGpPWpGaD
Reboxetine—SLC6A4—SIDS Susceptibility Pathways—NFKB1—primary biliary cirrhosis	0.000169	0.00254	CbGpPWpGaD
Reboxetine—ABCB1—Allograft Rejection—CD80—primary biliary cirrhosis	0.000168	0.00252	CbGpPWpGaD
Reboxetine—SLC6A2—Transmembrane transport of small molecules—ABCG2—primary biliary cirrhosis	0.000165	0.00249	CbGpPWpGaD
Reboxetine—HTR2C—Class A/1 (Rhodopsin-like receptors)—CXCL10—primary biliary cirrhosis	0.00016	0.00241	CbGpPWpGaD
Reboxetine—HTR2C—Gastrin-CREB signalling pathway via PKC and MAPK—AGT—primary biliary cirrhosis	0.000155	0.00234	CbGpPWpGaD
Reboxetine—HTR2C—GPCR downstream signaling—CXCR5—primary biliary cirrhosis	0.000145	0.00219	CbGpPWpGaD
Reboxetine—ABCB1—Integrated Pancreatic Cancer Pathway—TNFRSF1A—primary biliary cirrhosis	0.000145	0.00218	CbGpPWpGaD
Reboxetine—CYP2D6—Biological oxidations—GGT1—primary biliary cirrhosis	0.000138	0.00208	CbGpPWpGaD
Reboxetine—HTR2C—Class A/1 (Rhodopsin-like receptors)—CCL5—primary biliary cirrhosis	0.000138	0.00207	CbGpPWpGaD
Reboxetine—HTR2C—Signaling by GPCR—CXCR5—primary biliary cirrhosis	0.000132	0.00199	CbGpPWpGaD
Reboxetine—HTR2C—GPCR downstream signaling—CXCL9—primary biliary cirrhosis	0.000132	0.00199	CbGpPWpGaD
Reboxetine—SLC6A2—SLC-mediated transmembrane transport—ALB—primary biliary cirrhosis	0.000127	0.00191	CbGpPWpGaD
Reboxetine—HTR2C—GPCR ligand binding—CXCL10—primary biliary cirrhosis	0.000122	0.00183	CbGpPWpGaD
Reboxetine—HTR2C—Signaling by GPCR—CXCL9—primary biliary cirrhosis	0.00012	0.00181	CbGpPWpGaD
Reboxetine—HTR2C—Gastrin-CREB signalling pathway via PKC and MAPK—TYK2—primary biliary cirrhosis	0.000116	0.00175	CbGpPWpGaD
Reboxetine—HTR2C—Class A/1 (Rhodopsin-like receptors)—AGT—primary biliary cirrhosis	0.000115	0.00173	CbGpPWpGaD
Reboxetine—HTR2C—GPCR ligand binding—CCL5—primary biliary cirrhosis	0.000105	0.00158	CbGpPWpGaD
Reboxetine—ABCB1—Metabolism—LBR—primary biliary cirrhosis	0.000101	0.00152	CbGpPWpGaD
Reboxetine—CYP2D6—Metabolism—LBR—primary biliary cirrhosis	9.5e-05	0.00143	CbGpPWpGaD
Reboxetine—CYP3A4—Biological oxidations—GGT1—primary biliary cirrhosis	9.02e-05	0.00136	CbGpPWpGaD
Reboxetine—ABCB1—Transmembrane transport of small molecules—AQP4—primary biliary cirrhosis	8.94e-05	0.00135	CbGpPWpGaD
Reboxetine—HTR2C—GPCR ligand binding—AGT—primary biliary cirrhosis	8.77e-05	0.00132	CbGpPWpGaD
Reboxetine—ABCB1—Transmembrane transport of small molecules—ABCC2—primary biliary cirrhosis	8.57e-05	0.00129	CbGpPWpGaD
Reboxetine—HTR2C—Signaling Pathways—CDH5—primary biliary cirrhosis	8.11e-05	0.00122	CbGpPWpGaD
Reboxetine—ABCB1—Transmembrane transport of small molecules—NUP210—primary biliary cirrhosis	7.84e-05	0.00118	CbGpPWpGaD
Reboxetine—HTR2C—Signaling Pathways—CXCR5—primary biliary cirrhosis	7.8e-05	0.00117	CbGpPWpGaD
Reboxetine—ABCB1—Metabolism—OGDH—primary biliary cirrhosis	7.29e-05	0.0011	CbGpPWpGaD
Reboxetine—ABCB1—Transmembrane transport of small molecules—ABCG2—primary biliary cirrhosis	7.29e-05	0.0011	CbGpPWpGaD
Reboxetine—HTR2C—Signaling Pathways—CXCL9—primary biliary cirrhosis	7.08e-05	0.00107	CbGpPWpGaD
Reboxetine—HTR2C—GPCR downstream signaling—CXCL10—primary biliary cirrhosis	6.88e-05	0.00104	CbGpPWpGaD
Reboxetine—CYP2D6—Metabolism—OGDH—primary biliary cirrhosis	6.87e-05	0.00103	CbGpPWpGaD
Reboxetine—HTR2C—Signaling Pathways—ELMO1—primary biliary cirrhosis	6.56e-05	0.000987	CbGpPWpGaD
Reboxetine—ABCB1—Metabolism—PDHX—primary biliary cirrhosis	6.5e-05	0.000978	CbGpPWpGaD
Reboxetine—SLC6A2—Transmembrane transport of small molecules—ALB—primary biliary cirrhosis	6.46e-05	0.000972	CbGpPWpGaD
Reboxetine—HTR2C—Signaling by GPCR—CXCL10—primary biliary cirrhosis	6.25e-05	0.00094	CbGpPWpGaD
Reboxetine—CYP3A4—Metabolism—LBR—primary biliary cirrhosis	6.21e-05	0.000935	CbGpPWpGaD
Reboxetine—CYP2D6—Metabolism—PDHX—primary biliary cirrhosis	6.12e-05	0.000921	CbGpPWpGaD
Reboxetine—ABCB1—Metabolism—ABCB4—primary biliary cirrhosis	6.11e-05	0.000919	CbGpPWpGaD
Reboxetine—ABCB1—Metabolism—DLAT—primary biliary cirrhosis	6.11e-05	0.000919	CbGpPWpGaD
Reboxetine—HTR2C—GPCR downstream signaling—CCL5—primary biliary cirrhosis	5.92e-05	0.000891	CbGpPWpGaD
Reboxetine—CYP2D6—Metabolism—ABCB4—primary biliary cirrhosis	5.76e-05	0.000866	CbGpPWpGaD
Reboxetine—CYP2D6—Metabolism—DLAT—primary biliary cirrhosis	5.76e-05	0.000866	CbGpPWpGaD
Reboxetine—HTR2C—Signaling by GPCR—MMP3—primary biliary cirrhosis	5.7e-05	0.000858	CbGpPWpGaD
Reboxetine—ABCB1—Integrated Pancreatic Cancer Pathway—NFKB1—primary biliary cirrhosis	5.44e-05	0.000819	CbGpPWpGaD
Reboxetine—HTR2C—Signaling by GPCR—CCL5—primary biliary cirrhosis	5.38e-05	0.000809	CbGpPWpGaD
Reboxetine—HTR2C—GPCR downstream signaling—AGT—primary biliary cirrhosis	4.95e-05	0.000746	CbGpPWpGaD
Reboxetine—HTR2C—Signaling by GPCR—AGT—primary biliary cirrhosis	4.5e-05	0.000677	CbGpPWpGaD
Reboxetine—CYP3A4—Metabolism—OGDH—primary biliary cirrhosis	4.49e-05	0.000676	CbGpPWpGaD
Reboxetine—CYP3A4—Metabolism—PDHX—primary biliary cirrhosis	4e-05	0.000602	CbGpPWpGaD
Reboxetine—CYP3A4—Metabolism—DLAT—primary biliary cirrhosis	3.76e-05	0.000566	CbGpPWpGaD
Reboxetine—CYP3A4—Metabolism—ABCB4—primary biliary cirrhosis	3.76e-05	0.000566	CbGpPWpGaD
Reboxetine—HTR2C—Signaling Pathways—CXCL10—primary biliary cirrhosis	3.69e-05	0.000555	CbGpPWpGaD
Reboxetine—ABCB1—Metabolism—NUP210—primary biliary cirrhosis	3.67e-05	0.000553	CbGpPWpGaD
Reboxetine—CYP2D6—Metabolism—NUP210—primary biliary cirrhosis	3.46e-05	0.000521	CbGpPWpGaD
Reboxetine—ABCB1—Metabolism—ABCG2—primary biliary cirrhosis	3.41e-05	0.000514	CbGpPWpGaD
Reboxetine—HTR2C—Signaling Pathways—MMP3—primary biliary cirrhosis	3.37e-05	0.000507	CbGpPWpGaD
Reboxetine—HTR2C—Signaling by GPCR—TYK2—primary biliary cirrhosis	3.36e-05	0.000506	CbGpPWpGaD
Reboxetine—CYP2D6—Metabolism—ABCG2—primary biliary cirrhosis	3.22e-05	0.000484	CbGpPWpGaD
Reboxetine—HTR2C—Signaling Pathways—CCL5—primary biliary cirrhosis	3.18e-05	0.000478	CbGpPWpGaD
Reboxetine—HTR2C—Signaling Pathways—RPS6KB1—primary biliary cirrhosis	3.08e-05	0.000463	CbGpPWpGaD
Reboxetine—ABCB1—Metabolism—CTGF—primary biliary cirrhosis	2.93e-05	0.000441	CbGpPWpGaD
Reboxetine—ABCB1—Metabolism—GOT2—primary biliary cirrhosis	2.9e-05	0.000437	CbGpPWpGaD
Reboxetine—ABCB1—Transmembrane transport of small molecules—ALB—primary biliary cirrhosis	2.84e-05	0.000428	CbGpPWpGaD
Reboxetine—CYP2D6—Metabolism—CTGF—primary biliary cirrhosis	2.76e-05	0.000415	CbGpPWpGaD
Reboxetine—CYP2D6—Metabolism—GOT2—primary biliary cirrhosis	2.73e-05	0.000412	CbGpPWpGaD
Reboxetine—HTR2C—Signaling Pathways—HIF1A—primary biliary cirrhosis	2.67e-05	0.000401	CbGpPWpGaD
Reboxetine—HTR2C—Signaling Pathways—AGT—primary biliary cirrhosis	2.66e-05	0.0004	CbGpPWpGaD
Reboxetine—ABCB1—Metabolism—GGT1—primary biliary cirrhosis	2.5e-05	0.000377	CbGpPWpGaD
Reboxetine—ABCB1—Metabolism—GOT1—primary biliary cirrhosis	2.5e-05	0.000377	CbGpPWpGaD
Reboxetine—CYP2D6—Metabolism—GOT1—primary biliary cirrhosis	2.36e-05	0.000355	CbGpPWpGaD
Reboxetine—CYP2D6—Metabolism—GGT1—primary biliary cirrhosis	2.36e-05	0.000355	CbGpPWpGaD
Reboxetine—HTR2C—Signaling Pathways—CD80—primary biliary cirrhosis	2.35e-05	0.000354	CbGpPWpGaD
Reboxetine—CYP3A4—Metabolism—NUP210—primary biliary cirrhosis	2.26e-05	0.00034	CbGpPWpGaD
Reboxetine—ABCB1—Metabolism—PPARGC1A—primary biliary cirrhosis	2.23e-05	0.000336	CbGpPWpGaD
Reboxetine—CYP3A4—Metabolism—ABCG2—primary biliary cirrhosis	2.1e-05	0.000316	CbGpPWpGaD
Reboxetine—CYP2D6—Metabolism—PPARGC1A—primary biliary cirrhosis	2.1e-05	0.000316	CbGpPWpGaD
Reboxetine—HTR2C—Signaling Pathways—TYK2—primary biliary cirrhosis	1.99e-05	0.000299	CbGpPWpGaD
Reboxetine—CYP3A4—Metabolism—CTGF—primary biliary cirrhosis	1.8e-05	0.000272	CbGpPWpGaD
Reboxetine—CYP3A4—Metabolism—GOT2—primary biliary cirrhosis	1.79e-05	0.000269	CbGpPWpGaD
Reboxetine—ABCB1—Metabolism—AGT—primary biliary cirrhosis	1.74e-05	0.000261	CbGpPWpGaD
Reboxetine—CYP2D6—Metabolism—AGT—primary biliary cirrhosis	1.64e-05	0.000246	CbGpPWpGaD
Reboxetine—HTR2C—Signaling Pathways—MMP9—primary biliary cirrhosis	1.56e-05	0.000236	CbGpPWpGaD
Reboxetine—HTR2C—Signaling Pathways—NFKB1—primary biliary cirrhosis	1.55e-05	0.000233	CbGpPWpGaD
Reboxetine—CYP3A4—Metabolism—GOT1—primary biliary cirrhosis	1.54e-05	0.000232	CbGpPWpGaD
Reboxetine—CYP3A4—Metabolism—GGT1—primary biliary cirrhosis	1.54e-05	0.000232	CbGpPWpGaD
Reboxetine—CYP3A4—Metabolism—PPARGC1A—primary biliary cirrhosis	1.37e-05	0.000207	CbGpPWpGaD
Reboxetine—ABCB1—Metabolism—ALB—primary biliary cirrhosis	1.33e-05	0.000201	CbGpPWpGaD
Reboxetine—CYP2D6—Metabolism—ALB—primary biliary cirrhosis	1.26e-05	0.000189	CbGpPWpGaD
Reboxetine—CYP3A4—Metabolism—AGT—primary biliary cirrhosis	1.07e-05	0.000161	CbGpPWpGaD
Reboxetine—CYP3A4—Metabolism—ALB—primary biliary cirrhosis	8.21e-06	0.000124	CbGpPWpGaD
